CarboHyde and Emoviar PharmaCon GmbH Announce Strategic Collaboration in Sustained Release Technology
CarboHyde Zrt, a leader in cyclodextrin research and development, has entered into a strategic collaboration with Emoviar PharmaCon GmbH, a specialist in sustained release technologies.
This partnership aims to explore new business opportunities by leveraging CarboHyde’s expertise in cyclodextrins and Emoviar’s advanced sustained release formulations.
Through this collaboration, both companies will work together to identify and develop innovative applications, expanding market potential for their respective technologies.
“We are excited to join forces with Emoviar to unlock new possibilities in drug delivery and beyond”.
“Cyclodextrins have vast potential in pharmaceutical applications, and together, we can create cutting-edge solutions.”
For more information, please contact:
tamas.sohajda@carbohyde.com
